US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 211 actively recruiting studies with Utah sites out of 211 registered in total. The busiest research areas in Utah are Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (43), Phase 2 (64), Phase 3 (63), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
211
Recruiting Now
211
← Back to US Map
Top Conditions in Utah
Breast Cancer (6)Advanced Solid Tumor (5)Advanced Solid Tumors (4)Acute Myeloid Leukemia (4)Multiple Myeloma (3)Fallopian Tube Cancer (3)Ulcerative Colitis (3)Obesity (3)Overweight (3)Pancreatic Adenocarcinoma (3)Endometrial Cancer (3)Melanoma (3)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 211 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 211. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT05535166 Phase 2
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With...
Condition
Medulloblastoma
Enrollment
130 pts
Location
United States
Sponsor
St. Jude Children's Research H
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT06165653 N/A
Recruiting
Guided Meditation During Radiation Therapy for Brain Tumors
Condition
Brain Neoplasms
Enrollment
30 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT07215702 Phase 2
Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Parti...
Condition
Sepsis
Enrollment
124 pts
Location
United States, Argentina, Belgium
Sponsor
AstraZeneca
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT07681401 N/A
Recruiting
Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthoo...
Condition
Family Caregivers
Enrollment
10 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT04408430 N/A
Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Condition
Mitral Annular Calcification
Enrollment
210 pts
Location
United States, Mexico
Sponsor
Mayra Guerrero
View Trial →
NCT06469281 Phase 1
Recruiting
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Ther...
Condition
Epithelial Ovarian Cancer
Enrollment
90 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07533019 Phase 2
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Condition
Vitiligo
Enrollment
66 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
View Trial →
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
View Trial →
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT05516472 EARLY_Phase 1
Recruiting
Fecal Microbiota Transplantation in Kidney Stone Patients
Condition
Kidney Stones
Enrollment
36 pts
Location
United States
Sponsor
Joshua Stern
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT05568550 Phase 2
Recruiting
Pembro With Radiation With or Without Olaparib
Condition
Prostate Cancer
Enrollment
64 pts
Location
United States
Sponsor
Zin W Myint
View Trial →
NCT07477691 Phase 4
Recruiting
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
Condition
Phenylketonuria
Enrollment
12 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT07218926 Phase 3
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastr...
Condition
Gastrointestinal Neoplasms
Enrollment
450 pts
Location
United States, Australia, Belgium
Sponsor
GlaxoSmithKline
View Trial →
NCT06941415 Phase 3
Recruiting
Bumetanide vs. Furosemide in Cirrhosis
Condition
Cirrhosis
Enrollment
500 pts
Location
United States
Sponsor
Stacy Johnson
View Trial →
Page 1 of 9 — 211 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology